Anatara Lifesciences Ltd (AU:ANR) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Anatara Lifesciences Ltd successfully raised $274,500 through a Share Purchase Plan (SPP), complementing a recent $750,000 placement with institutional investors. The funds will support the company’s Phase II clinical study for its GaRP medication targeting irritable bowel syndrome and an anti-obesity project. This financial boost marks a significant step forward for Anatara’s innovative gastrointestinal and weight management solutions.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue